- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Insight Molecular Diagnostics Inc (IMDX)
Insight Molecular Diagnostics Inc stock price live, this page displays NASDAQ IMDX stock exchange data. View the IMDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Insight Molecular Diagnostics Inc real time stock price chart below.
What Is the Insight Molecular Diagnostics Inc Stock Price Today?
The Insight Molecular Diagnostics Inc stock price today is 2.540.
What Is the Stock Symbol for Insight Molecular Diagnostics Inc?
The stock symbol for Insight Molecular Diagnostics Inc is ""IMDX.""
What Stock Exchange Does Insight Molecular Diagnostics Inc Trade On?
Insight Molecular Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Insight Molecular Diagnostics Inc a Good Stock to Buy?
Determining whether Insight Molecular Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMDX quote. (ISIN: US68235C2061)
What Is the Insight Molecular Diagnostics Inc Stock Price Today?
The Insight Molecular Diagnostics Inc stock price today is 2.540.
What Is the Stock Symbol for Insight Molecular Diagnostics Inc?
The stock symbol for Insight Molecular Diagnostics Inc is ""IMDX.""
What Stock Exchange Does Insight Molecular Diagnostics Inc Trade On?
Insight Molecular Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Insight Molecular Diagnostics Inc a Good Stock to Buy?
Determining whether Insight Molecular Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMDX quote. (ISIN: US68235C2061)
2.540
-0.010(-0.39%)
Real-time Data·
Fair Value
An estimate of a Insight Molecular Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.331
2.570
52 wk Range
1.922
4.750
IMDX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IMDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Insight Molecular Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.3312.570
52 wk Range
1.9224.750
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Insight Molecular Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
5.417
Upside
+113.25%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Insight Molecular Diagnostics Inc Company Profile
Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers VitaGraft Kidney, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for kidney transplantation; VitaGraft Liver, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for liver transplantation; and GraftAssure, a dd-cfDNA test that uses droplet digital PCR technology to measure the concentration of dd-cfDNA using 48 predefined SNPs. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad’s ddPCR instruments and reagents. Insight Molecular Diagnostics Inc. was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.
Insight Molecular Diagnostics Inc Earnings Call Summary for Q1/2025
- Q1 pharma services revenue beat expectations at $2.1M, driven by a late-quarter order; stock fell 2.09% in regular trading
- Strong cash position of $33M; negative free cash flow of $6.2M aligns with quarterly target
- FDA submission planned for end of 2024, with approval expected in early 2026 for transplant rejection testing
- Strategic pivot towards transplant rejection testing and oncology diagnostics; potential corporate name change forthcoming
- Analyst consensus optimistic with price targets ranging from $4.00 to $5.00 per share
Last Updated: 12/05/2025, 22:50
Read Full TranscriptCompare IMDX to Peers and Sector
Metrics to compare | IMDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | 2.4x | −0.5x | |
PEG Ratio | −0.04 | 0.01 | 0.00 | |
Price/Book | 7.2x | 9.8x | 2.6x | |
Price / LTM Sales | 19.1x | 8.2x | 3.3x | |
Upside (Analyst Target) | 62.8% | 88.4% | 42.9% | |
Fair Value Upside | Unlock | 3.0% | 6.2% | Unlock |
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.417
(+113.25% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-0.26 / -0.66
Revenue / Forecast
2.14M / --
People Also Watch
FAQ
What Stock Exchange Does Insight Molecular Diagnostics Trade On?
Insight Molecular Diagnostics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Insight Molecular Diagnostics?
The stock symbol for Insight Molecular Diagnostics is "IMDX."
What Is the Insight Molecular Diagnostics Market Cap?
As of today, Insight Molecular Diagnostics market cap is 72.64M.
What Is Insight Molecular Diagnostics's Earnings Per Share (TTM)?
The Insight Molecular Diagnostics EPS (TTM) is -3.34.
From a Technical Analysis Perspective, Is IMDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Insight Molecular Diagnostics Stock Split?
Insight Molecular Diagnostics has split 1 times.
How Many Employees Does Insight Molecular Diagnostics Have?
Insight Molecular Diagnostics has 48 employees.
What is the current trading status of Insight Molecular Diagnostics (IMDX)?
As of 12 Aug 2025, Insight Molecular Diagnostics (IMDX) is trading at a price of 2.54, with a previous close of 2.61. The stock has fluctuated within a day range of 2.33 to 2.57, while its 52-week range spans from 1.92 to 4.75.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.